New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

AGNGvsHRTSETF Comparison

ETF 1
AGNG

Global X Aging Population ETF

This fund is part of
New Consumers & Focus
-0.5%
Full AGNG fund page
VS
ETF 2
HRTS

Tema GLP-1, Obesity & Cardiometabolic ETF

This fund is part of
Tomorrow's Treatments
-0.38%
Full HRTS fund page

Global X Aging Population ETF (AGNG) belongs to the New Consumers & Focus segment. Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) is part of the Tomorrow's Treatments segment. AGNG's top 3 sector exposures are Health Care and Real Estate. In contrast, HRTS's top sector exposures are Health Care  AGNG is less expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.99% for HRTS. AGNG is up 1.36% year-to-date (YTD) with +$12M in YTD flows. HRTS performs worse with -2.17% YTD performance, and -$713K in YTD flows. Run a side-by-side ETF comparison of AGNG and HRTS below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

AGNG vs HRTS performance and flow charts

Performance

-4.0-3.0-2.0-1.00.01.02.0%Feb 11Feb 19Feb 26Mar 5

Cumulative Flows

-2 M-1 M0 M1 M2 MFeb 11Feb 19Feb 26Mar 5

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/11/2026
1M3MYTD1Y3Y5Y
Perf.
AGNG
HRTS
-3.76%-2.82%
+1.69%-1.29%
+1.36%-2.17%
+17.03%+18.66%
+44.51%n/a
+36.62%n/a
Flows
AGNG
HRTS
+$2M-$2M
+$15M+$712K
+$12M-$713K
+$15M-$17M
+$3M-
+$30M-
Volatility and drawdown
3M1Y3Y5Y
Volatility
AGNG
HRTS
+10.89%+13.97%
+13.18%+17.56%
+11.50%n/a
+13.48%n/a
Max drawdown
AGNG
HRTS
-5.27%-6.15%
-10.62%-13.50%
-13.73%n/a
-25.40%n/a
Max drawdown duration
AGNG
HRTS
10d63d
80d163d
323dn/a
1041dn/a
Trading data

Create an account to view trading data

Join for free
AGNG
HRTS
Last sale
3/11/2026 at 1:30 PM
$36.43
$34.55
Previous close
03/11/2026
$36.67
$34.78
Consolidated volume
03/11/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

HRTS
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
AGNG
HRTS
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/11/2026 at 1:30 PM
Live
Closed
AGNG
HRTS
Last price
$36.43
$34.55
1D performance
-0.66%
-0.65%
AuM$84.61 M$52.88 M
E/R0.5%0.99%
Characteristics
AGNG
HRTS
Management strategyPassiveActive
ProviderGlobal XTema
BenchmarkIndxx Aging Population Thematic Index-
N° of holdings7639
Asset class--
Trailing 12m distribution yield
Join
Join
Inception dateMay 9, 2016November 21, 2023
ESGYesNo
Advertisement
Exposure

Countries

AGNG
USA
58.96%
Switzerland
10.87%
Other
30.16%
HRTS
USA
82.17%
Other
17.83%

Sectors

AGNG
Health Care
81.21%
Real Estate
7.44%
Other
11.35%
HRTS
Health Care
87.29%
Other
12.71%
Advertisement

Diversification

AGNG

Total weight of top 15 holdings out of 15

46.72%
HRTS

Total weight of top 15 holdings out of 15

61.09%

Top 15 holdings

Data as of January 31, 2026
AGNG
UCB
4.40%
JOHNSON&JOHNSON
3.53%
ROCHE
3.47%
US0463531089
3.33%
LILLY
3.30%
MERCK & CO INC
3.20%
WELLTOWER INC
3.17%
REGENERON PHARMACEUTICALS
3.12%
ABBVIE
2.93%
MEDTRONIC PLC
2.88%
CHUGAI PHARMACEUTICAL
2.86%
AMGEN-T
2.86%
EDWARDS LIFESCIENCES
2.83%
STRYKER
2.44%
CH1243598427
2.41%
HRTS
LILLY
9.89%
US7711951043
5.07%
JOHNSON&JOHNSON
4.52%
ASTRAZENECA
4.35%
THERMO FISHER SCIENTIFIC
4.30%
MERCK & CO INC
3.96%
UNITEDHEALTH GRP
3.92%
DK0062498333
3.54%
GILEAD SCIENCES
3.45%
NOVARTIS
3.21%
ABBOTT LABS
3.12%
BOSTON SCIENTIFIC
3.06%
MEDTRONIC PLC
2.97%
VERTEX PHARMACEUTICALS
2.88%
DANAHER
2.85%
Frequently asked questions about AGNG and HRTS

How have the AGNG and HRTS ETFs performed in 2026?

As of March 11, 2026, AGNG is up 1.36% year-to-date (YTD), while HRTS has lost -2.17%. That puts AGNG better performer ahead so far this year.

Which ETF is attracting more investor money: AGNG or HRTS?

Year-to-date, the AGNG ETF saw +$12M in flows, compared to -$713K for HRTS.

Which ETF is more volatile: AGNG or HRTS?

Over the past year, AGNG had a volatility of 13.18%, while HRTS experienced 17.56%.

Which ETF is bigger: AGNG or HRTS?

As of March 11, 2026, AGNG holds $84.61 M in assets under management (AUM), while HRTS manages $52.88 M.

What sectors do the AGNG and HRTS ETFs invest in?

AGNG leans toward sectors like Health Care and Real Estate. Meanwhile, HRTS focuses on Health Care.

What are the top holdings of the AGNG ETF and HRTS ETF?

AGNG top holdings include UCB, JOHNSON&JOHNSON and ROCHE. HRTS holds in its top three: LILLY, US7711951043 and JOHNSON&JOHNSON.

Which ETF is more diversified: AGNG or HRTS?

AGNG holds 80 securities with 46.72% of its assets in the top 15. HRTS has 44 securities and a top 15 weight of 61.09%.

Advertisement
Advertisement
Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast